Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Tatiana A Mishchenko"'
Autor:
Iuliia Efimova, Elena Catanzaro, Louis Van der Meeren, Victoria D Turubanova, Hamida Hammad, Tatiana A Mishchenko, Maria V Vedunova, Carmela Fimognari, Claus Bachert, Frauke Coppieters, Steve Lefever, Andre G Skirtach, Olga Krysko, Dmitri V Krysko
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Immunotherapy represents the future of clinical cancer treatment. The type of cancer cell death determines the antitumor immune response and thereby contributes to the efficacy of anticancer therapy and long-term survival of patients. Indu
Externí odkaz:
https://doaj.org/article/2a503d3f5540469a8ba20ba437a6ab07
Autor:
Tatiana A. Mishchenko, Maria O. Klimenko, Evgenii L. Guryev, Alexander G. Savelyev, Dmitri V. Krysko, Sergey V. Gudkov, Evgeny V. Khaydukov, Andrei V. Zvyagin, Maria V. Vedunova
Publikováno v:
Frontiers in Chemistry, Vol 12 (2024)
Targeted drug delivery for primary brain tumors, particularly gliomas, is currently a promising approach to reduce patient relapse rates. The use of substitutable scaffolds, which enable the sustained release of clinically relevant doses of anticance
Externí odkaz:
https://doaj.org/article/8bcba51acd8b4706a260f582b35579a7
Autor:
Faye Naessens, Robin Demuynck, Olga Vershinina, Iuliia Efimova, Mariia Saviuk, Greet De Smet, Tatiana A. Mishchenko, Maria V. Vedunova, Olga Krysko, Elena Catanzaro, Dmitri V. Krysko
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionImmunogenic cell death (ICD) has emerged as a novel option for cancer immunotherapy. The key determinants of ICD encompass antigenicity (the presence of antigens) and adjuvanticity, which involves the release of damage-associated molecula
Externí odkaz:
https://doaj.org/article/897c16da81f44a31844f4d82d76e5dbb
Autor:
Maria O. Klimenko, Tatiana A. Mishchenko, Yaroslava I. Mitaeva, Elena V. Kondakova, Elena V. Mitroshina, Maria V. Vedunova
Publikováno v:
Neurology International, Vol 15, Iss 3, Pp 778-791 (2023)
Sleep–wake cycle disorders most often accompany the elderly and are frequently associated with the development of neurodegenerative processes, primarily Alzheimer’s disease. Sleep disturbances can be diagnosed in patients with AD even before the
Externí odkaz:
https://doaj.org/article/fcaf1690cc4c42d7a15cb6e32baf6902
Autor:
Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, Olga Krysko, Maria V. Vedunova, Dmitri V. Krysko
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Glioma is the most common primary brain tumor, characterized by a consistently high patient mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial evidence underscores the vital role of the immune system in era
Externí odkaz:
https://doaj.org/article/671e1b3822144468a9b6f04b69832d42
Autor:
Tikhon S. Redkin, Ekaterina E. Sleptsova, Victoria D. Turubanova, Mariia O. Saviuk, Svetlana A. Lermontova, Larisa G. Klapshina, Nina N. Peskova, Irina V. Balalaeva, Olga Krysko, Tatiana A. Mishchenko, Maria V. Vedunova, Dmitri V. Krysko
Publikováno v:
Pharmaceutics, Vol 15, Iss 10, p 2430 (2023)
Research in the past decade on immunogenic cell death (ICD) has shown that the immunogenicity of dying tumor cells is crucial for effective anticancer therapy. ICD induction leads to the emission of specific damage-associated molecular patterns (DAMP
Externí odkaz:
https://doaj.org/article/314193d9eefd4e6b8210e90a43c89af4
Autor:
Tatiana A. Mishchenko, Maria O. Klimenko, Alisa I. Kuznetsova, Roman S. Yarkov, Alexander G. Savelyev, Anastasia V. Sochilina, Alexandra O. Mariyanats, Vladimir K. Popov, Evgeny V. Khaydukov, Andrei V. Zvyagin, Maria V. Vedunova
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Brain tissue reconstruction posttraumatic injury remains a long-standing challenge in neurotransplantology, where a tissue-engineering construct (scaffold, SC) with specific biochemical properties is deemed the most essential building block. Such thr
Externí odkaz:
https://doaj.org/article/6a6d24f87e354a179fad9c84502dd6eb
Autor:
Victoria D. Turubanova, Irina V. Balalaeva, Tatiana A. Mishchenko, Elena Catanzaro, Razan Alzeibak, Nina N. Peskova, Iuliia Efimova, Claus Bachert, Elena V. Mitroshina, Olga Krysko, Maria V. Vedunova, Dmitri V. Krysko
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Anti-cancer therapy is more successful when it can also induce an immunogenic form of cancer cell death (ICD). Therefore, when developing new treatment strategies, it is extremely important to choose methods that induce ICD and th
Externí odkaz:
https://doaj.org/article/74d9f8330b3f4837b030647ecc6865c1
Autor:
Angelina O. Kustova, Maria S. Gavrish, Marina A. Sergeeva, Daria A. Avlasenko, Anna O. Kiseleva, Ekaterina A. Epifanova, Alexey A. Babaev, Tatiana A. Mishchenko, Maria V. Vedunova
Publikováno v:
Brain Sciences, Vol 12, Iss 8, p 1039 (2022)
The high prevalence of diagnosed cases of severe neurological disorders, a significant proportion of which are epilepsy, contributes to a high level of mortality and disability in the population. Neurotrophic factors BDNF and GNDF are considered prom
Externí odkaz:
https://doaj.org/article/86057363dd3f4d1690f26d22b1a67287
Autor:
Maria O. Savyuk, Victoria D. Turubanova, Tatiana A. Mishchenko, Svetlana A. Lermontova, Larisa G. Klapshina, Dmitri V. Krysko, Maria V. Vedunova
Publikováno v:
Cells, Vol 11, Iss 7, p 1212 (2022)
The current efforts in photodynamic therapy (PDT) of brain cancer are focused on the development of novel photosensitizers with improved photodynamic properties, targeted specific localization, and sensitivity to the irradiation dose, ensuring the ef
Externí odkaz:
https://doaj.org/article/96d9810d63634ea1af2d2b419279b823